Healthcare
Gland Pharma Limited (GLAND)
Gland Pharma Limited (GLAND) is an NSE-listed Healthcare company. latest close ₹3,079.1, 1-day return -2.3%, 1-week return +7.1%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 7 Oct 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹3,079.1
- 1-day return
- -2.3%
- 1-week return
- +7.1%
- 1-month return
- +4.0%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 55.9
- ADX (14)
- 65.3
- ROC 10
- +5.8%
- vs 52W high
- -2.9%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹47,292 Cr
- P/E
- 41.9
- P/B
- 4.56
- ROE
- —
- D/E
- 2.74
- Net margin
- 16.8%
- Rev. growth YoY
- 26.3%
- Div. yield
- 70.0%
- 52W high
- ₹3,042
- 52W low
- ₹1,573.6
- EPS (TTM)
- ₹68.41
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return -2.3%
Latest 1-day price change versus the previous close.
- signal
1-week return +7.1%
GLAND has one of the larger 1-week moves in the latest return snapshot.
- signal
EMA stack is aligned up
Short EMAs are stacked above longer EMAs on the daily chart.
- signal
ADX(14) 65 — trend in force
ADX above 25 usually means a directional move is underway.
- signal
Within 2.9% of the 52-week high
Price is near the 52-week high on the latest technicals snapshot.
News & screener mentions
Recent QUANTSCASE daily posts that listed GLAND.
